UNLABELLED: Parechoviruses are human pathogens that cause diseases ranging from gastrointestinal disorders to encephalitis. Unlike those of most picornaviruses, parechovirus capsids are composed of only three subunits: VP0, VP1, and VP3. Here, we present the structure of a human parechovirus 1 (HPeV-1) virion determined to a resolution of 3.1 Å. We found that interactions among pentamers in the HPeV-1 capsid are mediated by the N termini of VP0s, which correspond to the capsid protein VP4 and the N-terminal part of the capsid protein VP2 of other picornaviruses. In order to facilitate delivery of the virus genome into the cytoplasm, the N termini of VP0s have to be released from contacts between pentamers and exposed at the particle surface, resulting in capsid disruption. A hydrophobic pocket, which can be targeted by capsid-binding antiviral compounds in many other picornaviruses, is not present in HPeV-1. However, we found that interactions between the HPeV-1 single-stranded RNA genome and subunits VP1 and VP3 in the virion impose a partial icosahedral ordering on the genome. The residues involved in RNA binding are conserved among all parechoviruses, suggesting a putative role of the genome in virion stability or assembly. Therefore, putative small molecules that could disrupt HPeV RNA-capsid protein interactions could be developed into antiviral inhibitors. IMPORTANCE: Human parechoviruses (HPeVs) are pathogens that cause diseases ranging from respiratory and gastrointestinal disorders to encephalitis. Recently, there have been outbreaks of HPeV infections in Western Europe and North America. We present the first atomic structure of parechovirus HPeV-1 determined by X-ray crystallography. The structure explains why HPeVs cannot be targeted by antiviral compounds that are effective against other picornaviruses. Furthermore, we found that the interactions of the HPeV-1 genome with the capsid resulted in a partial icosahedral ordering of the genome. The residues involved in RNA binding are conserved among all parechoviruses, suggesting an evolutionarily fixed role of the genome in virion assembly. Therefore, putative small molecules disrupting HPeV RNA-capsid protein interactions could be developed into antiviral inhibitors.

Central European Institute of Technology Masaryk University Brno Czech Republic

Zobrazit více v PubMed

Boivin G, Abed Y, Boucher FD. 2005. Human parechovirus 3 and neonatal infections. Emerg Infect Dis 11:103–105. doi:10.3201/eid1101.040606. PubMed DOI PMC

Schuffenecker I, Javouhey E, Gillet Y, Kugener B, Billaud G, Floret D, Lina B, Morfin F. 2012. Human parechovirus infections, Lyon, France, 2008-10: evidence for severe cases. J Clin Virol 54:337–341. doi:10.1016/j.jcv.2012.04.016. PubMed DOI

Wildenbeest JG, Wolthers KC, Straver B, Pajkrt D. 2013. Successful IVIG treatment of human parechovirus-associated dilated cardiomyopathy in an infant. Pediatrics 132:e243–e247. doi:10.1542/peds.2012-1136. PubMed DOI

Stanway G, Joki-Korpela P, Hyypia T. 2000. Human parechoviruses—biology and clinical significance. Rev Med Virol 10:57–69. PubMed

Esposito S, Rahamat-Langendoen J, Ascolese B, Senatore L, Castellazzi L, Niesters HG. 2014. Pediatric parechovirus infections. J Clin Virol 60:84–89. doi:10.1016/j.jcv.2014.03.003. PubMed DOI

Verboon-Maciolek MA, Groenendaal F, Hahn CD, Hellmann J, van Loon AM, Boivin G, de Vries LS. 2008. Human parechovirus causes encephalitis with white matter injury in neonates. Ann Neurol 64:266–273. doi:10.1002/ana.21445. PubMed DOI

Levorson RE, Jantausch BA, Wiedermann BL, Spiegel HM, Campos JM. 2009. Human parechovirus-3 infection: emerging pathogen in neonatal sepsis. Pediatr Infect Dis J 28:545–547. doi:10.1097/INF.0b013e318194596a. PubMed DOI

Wigand R, Sabin AB. 1961. Properties of ECHO types 22, 23 and 24 viruses. Arch Gesamte Virusforsch 11:224–247. doi:10.1007/BF01241688. PubMed DOI

. 1955. ENTERIC cytopathogenic human orphan (ECHO) viruses. Science 122:1187–1188. doi:10.1126/science.122.3181.1187. PubMed DOI

King AMQ, Adams MJ, Carstens EB, Lefkowitz EJ (ed). 2012. Virus taxonomy. Ninth report of the International Committee on Taxonomy of Viruses. Elsevier Academic Press, Waltham, MA.

Stanway G, Kalkkinen N, Roivainen M, Ghazi F, Khan M, Smyth M, Meurman O, Hyypia T. 1994. Molecular and biological characteristics of echovirus 22, a representative of a new picornavirus group. J Virol 68:8232–8238. PubMed PMC

Sun G, Wang Y, Tao G, Shen Q, Cao W, Chang X, Zhang W, Shao C, Yi M, Shao S, Yang Y. 2012. Complete genome sequence of a novel type of human parechovirus strain reveals natural recombination events. J Virol 86:8892–8893. doi:10.1128/JVI.01241-12. PubMed DOI PMC

Williams CH, Panayiotou M, Girling GD, Peard CI, Oikarinen S, Hyoty H, Stanway G. 2009. Evolution and conservation in human parechovirus genomes. J Gen Virol 90:1702–1712. doi:10.1099/vir.0.008813-0. PubMed DOI

Sedmak G, Nix WA, Jentzen J, Haupt TE, Davis JP, Bhattacharyya S, Pallansch MA, Oberste MS. 2010. Infant deaths associated with human parechovirus infection in Wisconsin. Clin Infect Dis 50:357–361. doi:10.1086/649863. PubMed DOI

Li L, Victoria J, Kapoor A, Naeem A, Shaukat S, Sharif S, Alam MM, Angez M, Zaidi SZ, Delwart E. 2009. Genomic characterization of novel human parechovirus type. Emerg Infect Dis 15:288–291. doi:10.3201/eid1502.080341. PubMed DOI PMC

Hyypia T, Horsnell C, Maaronen M, Khan M, Kalkkinen N, Auvinen P, Kinnunen L, Stanway G. 1992. A distinct picornavirus group identified by sequence analysis. Proc Natl Acad Sci U S A 89:8847–8851. doi:10.1073/pnas.89.18.8847. PubMed DOI PMC

Arnold E, Luo M, Vriend G, Rossmann MG, Palmenberg AC, Parks GD, Nicklin MJ, Wimmer E. 1987. Implications of the picornavirus capsid structure for polyprotein processing. Proc Natl Acad Sci U S A 84:21–25. doi:10.1073/pnas.84.1.21. PubMed DOI PMC

Basavappa R, Syed R, Flore O, Icenogle JP, Filman DJ, Hogle JM. 1994. Role and mechanism of the maturation cleavage of VP0 in poliovirus assembly: structure of the empty capsid assembly intermediate at 2.9 A resolution. Protein Sci 3:1651–1669. doi:10.1002/pro.5560031005. PubMed DOI PMC

Stanway G, Hyypia T. 1999. Parechoviruses. J Virol 73:5249–5254. PubMed PMC

Rossmann MG. 1989. The canyon hypothesis. Hiding the host cell receptor attachment site on a viral surface from immune surveillance. J Biol Chem 264:14587–14590. PubMed

He Y, Chipman PR, Howitt J, Bator CM, Whitt MA, Baker TS, Kuhn RJ, Anderson CW, Freimuth P, Rossmann MG. 2001. Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor. Nat Struct Biol 8:874–878. doi:10.1038/nsb1001-874. PubMed DOI PMC

Xiao C, Bator CM, Bowman VD, Rieder E, He Y, Hebert B, Bella J, Baker TS, Wimmer E, Kuhn RJ, Rossmann MG. 2001. Interaction of coxsackievirus A21 with its cellular receptor, ICAM-1. J Virol 75:2444–2451. doi:10.1128/JVI.75.5.2444-2451.2001. PubMed DOI PMC

Olson NH, Kolatkar PR, Oliveira MA, Cheng RH, Greve JM, McClelland A, Baker TS, Rossmann MG. 1993. Structure of a human rhinovirus complexed with its receptor molecule. Proc Natl Acad Sci U S A 90:507–511. doi:10.1073/pnas.90.2.507. PubMed DOI PMC

Boonyakiat Y, Hughes PJ, Ghazi F, Stanway G. 2001. Arginine-glycine-aspartic acid motif is critical for human parechovirus 1 entry. J Virol 75:10000–10004. doi:10.1128/JVI.75.20.10000-10004.2001. PubMed DOI PMC

Seitsonen J, Susi P, Heikkila O, Sinkovits RS, Laurinmaki P, Hyypia T, Butcher SJ. 2010. Interaction of alphaVbeta3 and alphaVbeta6 integrins with human parechovirus 1. J Virol 84:8509–8519. doi:10.1128/JVI.02176-09. PubMed DOI PMC

Rossmann MG, He Y, Kuhn RJ. 2002. Picornavirus-receptor interactions. Trends Microbiol 10:324–331. doi:10.1016/S0966-842X(02)02383-1. PubMed DOI

Filman DJ, Syed R, Chow M, Macadam AJ, Minor PD, Hogle JM. 1989. Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. EMBO J 8:1567–1579. PubMed PMC

Smyth M, Tate J, Hoey E, Lyons C, Martin S, Stuart D. 1995. Implications for viral uncoating from the structure of bovine enterovirus. Nat Struct Biol 2:224–231. doi:10.1038/nsb0395-224. PubMed DOI

Smyth M, Pettitt T, Symonds A, Martin J. 2003. Identification of the pocket factors in a picornavirus. Arch Virol 148:1225–1233. doi:10.1007/s00705-002-0974-4. PubMed DOI

Plevka P, Perera R, Yap ML, Cardosa J, Kuhn RJ, Rossmann MG. 2013. Structure of human enterovirus 71 in complex with a capsid-binding inhibitor. Proc Natl Acad Sci U S A 110:5463–5467. doi:10.1073/pnas.1222379110. PubMed DOI PMC

Bakker SE, Groppelli E, Pearson AR, Stockley PG, Rowlands DJ, Ranson NA. 2014. Limits of structural plasticity in a picornavirus capsid revealed by a massively expanded equine rhinitis A virus particle. J Virol 88:6093–6099. doi:10.1128/JVI.01979-13. PubMed DOI PMC

Fuchs R, Blaas D. 2012. Productive entry pathways of human rhinoviruses. Adv Virol 2012:826301. doi:10.1155/2012/826301. PubMed DOI PMC

Garriga D, Pickl-Herk A, Luque D, Wruss J, Caston JR, Blaas D, Verdaguer N. 2012. Insights into minor group rhinovirus uncoating: the X-ray structure of the HRV2 empty capsid. PLoS Pathog 8:e1002473. doi:10.1371/journal.ppat.1002473. PubMed DOI PMC

Levy HC, Bostina M, Filman DJ, Hogle JM. 2010. Catching a virus in the act of RNA release: a novel poliovirus uncoating intermediate characterized by cryo-electron microscopy. J Virol 84:4426–4441. doi:10.1128/JVI.02393-09. PubMed DOI PMC

Bostina M, Levy H, Filman DJ, Hogle JM. 2011. Poliovirus RNA is released from the capsid near a twofold symmetry axis. J Virol 85:776–783. doi:10.1128/JVI.00531-10. PubMed DOI PMC

Shakeel S. 2014. Human picornaviruses: uncoating, assembly and interaction with cellular receptors. University of Helsinki, Helsinki, Finland.

De Palma AM, Vliegen I, De Clercq E, Neyts J. 2008. Selective inhibitors of picornavirus replication. Med Res Rev 28:823–884. doi:10.1002/med.20125. PubMed DOI

Thibaut HJ, De Palma AM, Neyts J. 2012. Combating enterovirus replication: state-of-the-art on antiviral research. Biochem Pharmacol 83:185–192. doi:10.1016/j.bcp.2011.08.016. PubMed DOI

Smith TJ, Kremer MJ, Luo M, Vriend G, Arnold E, Kamer G, Rossmann MG, McKinlay MA, Diana GD, Otto MJ. 1986. The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science 233:1286–1293. doi:10.1126/science.3018924. PubMed DOI

Grant RA, Hiremath CN, Filman DJ, Syed R, Andries K, Hogle JM. 1994. Structures of poliovirus complexes with anti-viral drugs: implications for viral stability and drug design. Curr Biol 4:784–797. PubMed

Rotbart HA. 2000. Antiviral therapy for enteroviruses and rhinoviruses. Antivir Chem Chemother 11:261–271. doi:10.1177/095632020001100402. PubMed DOI

Rotbart HA, Webster AD, Pleconaril Treatment Registry Group . 2001. Treatment of potentially life-threatening enterovirus infections with pleconaril. Clin Infect Dis 32:228–235. doi:10.1086/318452. PubMed DOI

van de Ven AA, Douma JW, Rademaker C, van Loon AM, Wensing AM, Boelens JJ, Sanders EA, van Montfrans JM. 2011. Pleconaril-resistant chronic parechovirus-associated enteropathy in agammaglobulinaemia. Antivir Ther 16:611–614. doi:10.3851/IMP1792. PubMed DOI

Kabsch W. 2010. Xds. Acta Crystallogr D Biol Crystallogr 66:125–132. doi:10.1107/S0907444909047337. PubMed DOI PMC

Winn MD, Ballard CC, Cowtan KD, Dodson EJ, Emsley P, Evans PR, Keegan RM, Krissinel EB, Leslie AG, McCoy A, McNicholas SJ, Murshudov GN, Pannu NS, Potterton EA, Powell HR, Read RJ, Vagin A, Wilson KS. 2011. Overview of the CCP4 suite and current developments. Acta Crystallogr D Biol Crystallogr 67:235–242. doi:10.1107/S0907444910045749. PubMed DOI PMC

Evans P. 2006. Scaling and assessment of data quality. Acta Crystallogr D Biol Crystallogr 62:72–82. doi:10.1107/S0907444905036693. PubMed DOI

Tong L, Rossmann MG. 1997. Rotation function calculations with GLRF program. Methods Enzymol 276:594–611. doi:10.1016/S0076-6879(97)76080-4. PubMed DOI

Rossmann MG, Blow DM. 1962. Detection of sub-units within crystallographic asymmetric unit. Acta Crystallogr 15:24–31. doi:10.1107/S0365110X62000067. DOI

Brunger AT, Adams PD, Clore GM, DeLano WL, Gros P, Grosse-Kunstleve RW, Jiang JS, Kuszewski J, Nilges M, Pannu NS, Read RJ, Rice LM, Simonson T, Warren GL. 1998. Crystallography and NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr 54:905–921. PubMed

Brunger AT. 2007. Version 1.2 of the crystallography and NMR system. Nat Protoc 2:2728–2733. doi:10.1038/nprot.2007.406. PubMed DOI

Kleywegt GJ, Read RJ. 1997. Not your average density. Structure 5:1557–1569. doi:10.1016/S0969-2126(97)00305-5. PubMed DOI

Kleywegt GJ, Jones TA. 1999. Software for handling macromolecular envelopes. Acta Crystallogr D Biol Crystallogr 55:941–944. doi:10.1107/S0907444999001031. PubMed DOI

Rossmann MG. 1995. Ab initio phase determination and phase extension using non-crystallographic symmetry. Curr Opin Struct Biol 5:650–655. doi:10.1016/0959-440X(95)80058-1. PubMed DOI

Read RJ. 1986. Improved Fourier coefficients for maps using phases from partial structures with errors. Acta Crystallogr A 42:140–149. doi:10.1107/S0108767386099622. DOI

Kleywegt GJ. 1999. Experimental assessment of differences between related protein crystal structures. Acta Crystallogr D Biol Crystallogr 55:1878–1884. doi:10.1107/S0907444999010495. PubMed DOI

Cowtan K. 2006. The Buccaneer software for automated model building. 1. Tracing protein chains. Acta Crystallogr D Biol Crystallogr 62:1002–1011. doi:10.1107/S0907444906022116. PubMed DOI

Cowtan K. 2008. Fitting molecular fragments into electron density. Acta Crystallogr D Biol Crystallogr 64:83–89. doi:10.1107/S0907444907033938. PubMed DOI PMC

Emsley P, Cowtan K. 2004. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60:2126–2132. doi:10.1107/S0907444904019158. PubMed DOI

Jones TA, Zou JY, Cowan SW, Kjeldgaard M. 1991. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A 47:110–119. doi:10.1107/S0108767390010224. PubMed DOI

Kleywegt GJ, Jones TA. 1994. Detection, delineation, measurement and display of cavities in macromolecular structures. Acta Crystallogr D Biol Crystallogr 50:178–185. doi:10.1107/S0907444993011333. PubMed DOI

Chenna R, Sugawara H, Koike T, Lopez R, Gibson TJ, Higgins DG, Thompson JD. 2003. Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res 31:3497–3500. doi:10.1093/nar/gkg500. PubMed DOI PMC

Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. 2004. UCSF Chimera—a visualization system for exploratory research and analysis. J Comput Chem 25:1605–1612. doi:10.1002/jcc.20084. PubMed DOI

Xiao C, Rossmann MG. 2007. Interpretation of electron density with stereographic roadmap projections. J Struct Biol 158:182–187. doi:10.1016/j.jsb.2006.10.013. PubMed DOI PMC

Malod-Dognin N, Przulj N. 2014. GR-Align: fast and flexible alignment of protein 3D structures using graphlet degree similarity. Bioinformatics 30:1259–1265. doi:10.1093/bioinformatics/btu020. PubMed DOI

Huson DH. 1998. SplitsTree: analyzing and visualizing evolutionary data. Bioinformatics 14:68–73. doi:10.1093/bioinformatics/14.1.68. PubMed DOI

Kleywegt GJ, Brunger AT. 1996. Checking your imagination: applications of the free R value. Structure 4:897–904. doi:10.1016/S0969-2126(96)00097-4. PubMed DOI

Wang X, Ren J, Gao Q, Hu Z, Sun Y, Li X, Rowlands DJ, Yin W, Wang J, Stuart DI, Rao Z, Fry EE. 2015. Hepatitis A virus and the origins of picornaviruses. Nature 517:85–88. doi:10.1038/nature13806. PubMed DOI PMC

Logan D, Abu-Ghazaleh R, Blakemore W, Curry S, Jackson T, King A, Lea S, Lewis R, Newman J, Parry N, Rowlands D, Stuart D, Fry E. 1993. Structure of a major immunogenic site on foot-and-mouth disease virus. Nature 362:566–568. doi:10.1038/362566a0. PubMed DOI

Shakeel S, Seitsonen JJ, Kajander T, Laurinmaki P, Hyypia T, Susi P, Butcher SJ. 2013. Structural and functional analysis of coxsackievirus A9 integrin alphavbeta6 binding and uncoating. J Virol 87:3943–3951. doi:10.1128/JVI.02989-12. PubMed DOI PMC

Hendry E, Hatanaka H, Fry E, Smyth M, Tate J, Stanway G, Santti J, Maaronen M, Hyypia T, Stuart D. 1999. The crystal structure of coxsackievirus A9: new insights into the uncoating mechanisms of enteroviruses. Structure 7:1527–1538. doi:10.1016/S0969-2126(00)88343-4. PubMed DOI

Joki-Korpela P, Roivainen M, Lankinen H, Poyry T, Hyypia T. 2000. Antigenic properties of human parechovirus 1. J Gen Virol 81:1709–1718. doi:10.1099/0022-1317-81-7-1709. PubMed DOI

Alho A, Marttila J, Ilonen J, Hyypia T. 2003. Diagnostic potential of parechovirus capsid proteins. J Clin Microbiol 41:2294–2299. doi:10.1128/JCM.41.6.2294-2299.2003. PubMed DOI PMC

Roivainen M, Piirainen L, Rysa T, Narvanen A, Hovi T. 1993. An immunodominant N-terminal region of VP1 protein of poliovirion that is buried in crystal structure can be exposed in solution. Virology 195:762–765. doi:10.1006/viro.1993.1427. PubMed DOI

Park KB, Lim BK, Ye MB, Chung SY, Nam JH. 2012. A peptide vaccine based on a B-cell epitope on the VP1 protein of enterovirus 70 induces a strong antibody response. Acta Virol 56:337–342. doi:10.4149/av_2012_04_337. PubMed DOI

Lin J, Lee LY, Roivainen M, Filman DJ, Hogle JM, Belnap DM. 2012. Structure of the Fab-labeled “breathing” state of native poliovirus. J Virol 86:5959–5962. doi:10.1128/JVI.05990-11. PubMed DOI PMC

Hadfield AT, Lee W, Zhao R, Oliveira MA, Minor I, Rueckert RR, Rossmann MG. 1997. The refined structure of human rhinovirus 16 at 2.15 A resolution: implications for the viral life cycle. Structure 5:427–441. doi:10.1016/S0969-2126(97)00199-8. PubMed DOI

Arnold E, Rossmann MG. 1990. Analysis of the structure of a common cold virus, human rhinovirus 14, refined at a resolution of 3.0 A. J Mol Biol 211:763–801. doi:10.1016/0022-2836(90)90076-X. PubMed DOI

Chen ZG, Stauffacher C, Li Y, Schmidt T, Bomu W, Kamer G, Shanks M, Lomonossoff G, Johnson JE. 1989. Protein-RNA interactions in an icosahedral virus at 3.0 A resolution. Science 245:154–159. doi:10.1126/science.2749253. PubMed DOI

Davis IW, Leaver-Fay A, Chen VB, Block JN, Kapral GJ, Wang X, Murray LW, Arendall WB III, Snoeyink J, Richardson JS, Richardson DC. 2007. MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res 35:W375–W383. doi:10.1093/nar/gkm216. PubMed DOI PMC

Structure of deformed wing virus, a major honey bee pathogen

Virion Structure of Black Queen Cell Virus, a Common Honeybee Pathogen

Cryo-electron Microscopy Study of the Genome Release of the Dicistrovirus Israeli Acute Bee Paralysis Virus

Structure of Aichi Virus 1 and Its Empty Particle: Clues to Kobuvirus Genome Release Mechanism

Virion Structure of Iflavirus Slow Bee Paralysis Virus at 2.6-Angstrom Resolution

Zobrazit více v PubMed

PDB
1FOD